Work

Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation

Year: 2025

Type: article

Source: Acta Pharmacologica Sinica

DOI: 10.1038/s41401-025-01600-z

Authors: Zhen-chuan Wang, Chen Li, Zhao Zhang, Shan Lu, Ying-min Liu, Peng Qi, Xi Chen, Yu-bo Wang, Wen-jie Feng, Cheng-liang Pan, Qing-xuan Wang, Zhi-lin Ji, Ying Yu, Mei-hua Piao, Guang-fan Chi, Peng-fei Ge

Institutions: First Hospital of Jilin University, Jilin University, Second Affiliated Hospital of Jilin University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Chinese Academy of Sciences, People's Government of Jilin Province, Changchun Institute of Applied Chemistry, First Hospital of Jilin University

OpenAlex ID: W4411201997

FWCI: 5.486

Cites: 53

Cited by: 14

Related to: 10